Dr David Smotrich: Building the Future of Families

By Ashley Foster-Kane

Dr David Smotrich

For more than three decades, Dr. David Smotrich has helped redefine what is possible in reproductive medicine. As Founder and Medical Director of La Jolla IVF, he has spent his career advancing fertility treatment through innovation, compassion, and an unwavering commitment to helping individuals and couples build families.

Throughout his career, Dr. Smotrich has remained at the forefront of groundbreaking reproductive technologies. From helping pioneer blastocyst embryo culture and intracytoplasmic sperm injection (ICSI) to advancing preimplantation genetic testing, egg donation, gestational surrogacy, and fertility preservation, many of the tools now considered standard in modern fertility care were once revolutionary concepts. These advances have dramatically improved success rates while expanding options for patients facing infertility, age-related reproductive challenges, genetic concerns, or complex family-building circumstances.

Map courtesy of La Jolla IVF, illustrating the global reach of families created through Dr. David Smotrich's work.

In recognition of his contributions to the field, Dr. Smotrich received the American Fertility Association's Visionary Award in 2007, presented by Angela Bassett and Courtney B. Vance, honoring his groundbreaking work in fertility treatment, surrogacy, and reproductive innovation.

Among the most significant advances has been the evolution of genetic embryo screening. Today, physicians can evaluate embryos for chromosomal abnormalities before implantation, providing critical insight into embryo viability while helping reduce the emotional and physical burden of repeated unsuccessful treatment cycles. According to Dr. Smotrich, nearly 91 percent of embryos produced by women at age 45 are genetically abnormal, underscoring the importance of precision medicine in reproductive care. Technologies that once seemed futuristic now allow physicians to make more informed decisions, improving outcomes while creating increasingly personalized treatment plans.

Yet Dr. Smotrich's impact extends well beyond the science.

Long before LGBTQ+ family building entered mainstream conversation, he was helping same-sex couples pursue parenthood through assisted reproductive technology. In the mid-1990s, he became one of the earliest fertility specialists in the United States to advocate for gay intended parents, creating pathways to parenthood at a time when legal protections and social acceptance were far from guaranteed.

One of the defining moments of his career came in 1998, when he helped a same-sex male couple welcome a daughter through gestational surrogacy. One of the fathers, who was an attorney, successfully argued his own case and secured the first parentage judgment recognizing a same-sex couple in a gestational surrogacy arrangement. The landmark decision challenged existing legal norms and helped advance broader conversations surrounding parental equality. While reproductive medicine had evolved rapidly, the law had not yet caught up. Dr. Smotrich's willingness to advocate for his patients demonstrated that innovation is measured not only by scientific breakthroughs, but also by the courage to challenge outdated systems.

Today, La Jolla IVF has helped facilitate thousands of LGBTQ+ family-building journeys and has become an international destination for intended parents seeking expertise in fertility treatment, egg donation, and surrogacy. The practice also serves military veterans, cancer survivors preserving fertility before treatment, single parents by choice, and individuals pursuing parenthood later in life. Regardless of background or circumstance, Dr. Smotrich believes every patient deserves a personalized path forward.

"Science is only part of the equation," says Dr. Smotrich. "The human side of fertility care matters just as much."

That philosophy continues to shape his vision for the future.

As reproductive medicine enters a new era, Dr. Smotrich and his team are exploring emerging technologies, including artificial intelligence, regenerative therapies such as platelet-rich plasma (PRP), and increasingly sophisticated methods of embryo selection. Artificial intelligence has the potential to analyze embryo development with unprecedented precision, while regenerative therapies may offer new possibilities for patients with diminished ovarian reserve and other fertility challenges.

At the same time, fertility medicine continues to raise complex ethical questions surrounding reproductive autonomy, genetic selection, and the use of reproductive tissue from deceased donors. For Dr. Smotrich, navigating these advancements requires balancing scientific progress with compassion, responsibility, and respect for the deeply personal decisions patients face.

Despite the extraordinary technology now available, he remains quick to credit the collaborative effort behind every success story.

"Fertility treatment is ultimately a team endeavor," Dr. Smotrich shares. "Relying on the expertise of nurses, physicians, genetic specialists, and my support staff who work together to guide patients through one of the most significant journeys of their lives is why La Jolla IVF is successful."

With a career defined by scientific innovation, legal advocacy, and an unwavering commitment to expanding access to parenthood, Dr. David Smotrich has helped shape not only the future of reproductive medicine, but the future of family itself. As fertility technology continues to evolve, his mission remains remarkably simple: helping people achieve one of life's most meaningful aspirations—the opportunity to create a family.

Story by Ashley Foster-Kane
Photography/Images courtesy of La Jolla IVF.